• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促红细胞生成素受体的酪氨酸残基对于人类CD34+祖细胞的红系分化并非必需。

Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors.

作者信息

Fichelson S, Chrétien S, Rokicka-Piotrowicz M, Bouhanik S, Gisselbrecht S, Mayeux P, Lacombe C

机构信息

Laboratoire d'Hématopoïèse, Site Transfusionnel ETS, Hôpital Cochin, Institut National de la Transfusion Sanguine (INTS-GIP), 6 rue Alexandre Cabanel, Paris, F75015, France.

出版信息

Biochem Biophys Res Commun. 1999 Mar 24;256(3):685-91. doi: 10.1006/bbrc.1999.0340.

DOI:10.1006/bbrc.1999.0340
PMID:10080960
Abstract

To study the role of the cytoplasmic domain and particularly the tyrosine residues of the erythropoietin receptor (EpoR) in erythroid differentiation of human primary stem cells, we infected cord blood-derived CD34+ cells with retroviruses encoding chimeric receptors containing the extracellular domain of the prolactin receptor (PRLR) and the cytoplasmic domain of either the normal EpoR or a truncated EpoR devoid of tyrosine residues. Erythroid differentiation of the infected progenitors could thus be studied after stimulation by PRL. The complete PRLR was used to assess its ability to substitute for EpoR in erythroid differentiation. Typical erythroid day-14 colonies were observed from CD34+ cells grown in PRL when infected with any of the three viral constructs. These results demonstrate that: (i) the activation of the virally transduced PRLR leads to erythroid colony formation showing that erythroid terminal differentiation can be induced by a non-erythroid receptor in human progenitors; (ii) a chimeric receptor PRLR/EpoR is able to transduce a signal leading to terminal erythroid differentiation of human CD34+ cells; (iii) in contrast to results previously reported in murine models, tyrosine residues of the EpoR are not required for growth and terminal differentiation of human erythroid progenitors.

摘要

为了研究细胞质结构域尤其是促红细胞生成素受体(EpoR)的酪氨酸残基在人类原代干细胞红系分化中的作用,我们用编码嵌合受体的逆转录病毒感染脐带血来源的CD34+细胞,这些嵌合受体包含催乳素受体(PRLR)的胞外结构域和正常EpoR或不含酪氨酸残基的截短EpoR的细胞质结构域。因此,在催乳素刺激后,可以研究受感染祖细胞的红系分化。完整的PRLR用于评估其在红系分化中替代EpoR的能力。当用三种病毒构建体中的任何一种感染时,在催乳素中生长的CD34+细胞中观察到典型的第14天红系集落。这些结果表明:(i)病毒转导的PRLR的激活导致红系集落形成,表明人类祖细胞中的非红系受体可以诱导红系终末分化;(ii)嵌合受体PRLR/EpoR能够转导导致人类CD34+细胞终末红系分化的信号;(iii)与先前在小鼠模型中报道的结果相反,EpoR的酪氨酸残基对于人类红系祖细胞的生长和终末分化不是必需的。

相似文献

1
Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors.促红细胞生成素受体的酪氨酸残基对于人类CD34+祖细胞的红系分化并非必需。
Biochem Biophys Res Commun. 1999 Mar 24;256(3):685-91. doi: 10.1006/bbrc.1999.0340.
2
Enhancement of proliferation and differentiation of erythroid progenitors by co-transduction of erythropoietin receptor and H-ras cDNAS into single CD34(3+) cord blood cells.通过将促红细胞生成素受体和H-ras cDNA共转导至单个CD34(3+)脐血细胞中增强红系祖细胞的增殖和分化
Bone Marrow Transplant. 2000 Oct;26(8):817-22. doi: 10.1038/sj.bmt.1702620.
3
Total saponins of Panax ginseng (TSPG) promote erythroid differentiation of human CD34+ cells via EpoR-mediated JAK2/STAT5 signaling pathway.人参总皂苷通过 EpoR 介导的 JAK2/STAT5 信号通路促进人 CD34+细胞的红系分化。
J Ethnopharmacol. 2009 Nov 12;126(2):215-20. doi: 10.1016/j.jep.2009.08.043. Epub 2009 Sep 6.
4
Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.逆转录病毒介导的重组人促红细胞生成素受体和白细胞介素-9受体基因转导至单个CD34++CD33-或低含量脐带血细胞中对细胞因子刺激的红系集落形成的影响
Exp Hematol. 1996 Feb;24(2):347-51.
5
Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells.H-ras在TF1和人脐带血CD34细胞红系分化中的作用。
Blood Cells Mol Dis. 1998 Jun;24(2):124-36; discussion 137. doi: 10.1006/bcmd.1998.0179.
6
Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies.将人白细胞介素-9受体基因转导至人脐血红系祖细胞中可增加促红细胞生成素依赖性红系集落的数量。
Bone Marrow Transplant. 1996 Dec;18(6):1103-9.
7
The prolactin receptor rescues EpoR-/- erythroid progenitors and replaces EpoR in a synergistic interaction with c-kit.催乳素受体可挽救促红细胞生成素受体基因敲除(EpoR-/-)的红系祖细胞,并在与c-kit的协同相互作用中替代促红细胞生成素受体。
Blood. 1998 Sep 1;92(5):1491-6.
8
Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.促红细胞生成素诱导人红白血病细胞系TF-1向红系分化与STAT5激活受损相关。
EMBO J. 1996 Aug 15;15(16):4174-81.
9
Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.人脐带血CD34(+)CD38(-)Lin(-)细胞中自分泌转化生长因子-β的中和作用可促进干细胞因子介导的不依赖促红细胞生成素的早期红系祖细胞发育,并减少终末分化。
Stem Cells. 2003;21(5):557-67. doi: 10.1634/stemcells.21-5-557.
10
Enhancing effects of co-transduction of both human erythropoietin receptor and c-kit cDNAs into hematopoietic stem/progenitor cells from cord blood on proliferation and differentiation of erythroid progenitors.将人促红细胞生成素受体和c-kit cDNA共转导至脐血造血干/祖细胞中对红系祖细胞增殖和分化的增强作用。
Cytokines Cell Mol Ther. 2000 Mar;6(1):1-8. doi: 10.1080/13684730050515859.

引用本文的文献

1
Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.促红细胞生成素诱导的磷脂酰肌醇3激酶/蛋白激酶B使红系分化因子GATA-1能够激活金属蛋白酶组织抑制因子-1(TIMP-1)基因的转录。
Mol Cell Biol. 2005 Sep;25(17):7412-22. doi: 10.1128/MCB.25.17.7412-7422.2005.
2
PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors.PI3激酶对于促红细胞生成素刺激的人类红系祖细胞的Ras、MEK和Erk激活很重要。
BMC Biol. 2004 May 18;2:7. doi: 10.1186/1741-7007-2-7.